231 related articles for article (PubMed ID: 28601293)
1. From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
Wallwitz U; Brock S; Schunck A; Wildemann B; Jarius S; Hoffmann F
J Neuroimmunol; 2017 Aug; 309():77-81. PubMed ID: 28601293
[TBL] [Abstract][Full Text] [Related]
2. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B
J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318
[TBL] [Abstract][Full Text] [Related]
3. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
Jarius S; Martínez-García P; Hernandez AL; Brase JC; Borowski K; Regula JU; Meinck HM; Stöcker W; Wildemann B; Wandinger KP
J Neuroinflammation; 2013 Jan; 10():7. PubMed ID: 23320754
[TBL] [Abstract][Full Text] [Related]
4. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.
Doss S; Nümann A; Ziegler A; Siebert E; Borowski K; Stöcker W; Prüss H; Wildemann B; Endres M; Jarius S
J Neuroimmunol; 2014 Feb; 267(1-2):102-4. PubMed ID: 24439423
[TBL] [Abstract][Full Text] [Related]
5. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.
Jarius S; Wandinger KP; Horn S; Heuer H; Wildemann B
J Neuroinflammation; 2010 Mar; 7():21. PubMed ID: 20226058
[TBL] [Abstract][Full Text] [Related]
6. Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies.
Jarius S; Wildemann B; Stöcker W; Moser A; Wandinger KP
J Neuroimmunol; 2015 Sep; 286():79-82. PubMed ID: 26298328
[TBL] [Abstract][Full Text] [Related]
7. Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis.
Jarius S; Haas J; Wildemann B
J Neurol; 2023 Mar; 270(3):1776-1780. PubMed ID: 36333454
[No Abstract] [Full Text] [Related]
8. Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment.
Bartels F; Prüss H; Finke C
Front Neurol; 2018; 9():656. PubMed ID: 30158896
[TBL] [Abstract][Full Text] [Related]
9. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L
J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830
[TBL] [Abstract][Full Text] [Related]
11. Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years.
Schegk E; Beiser I; Achtnichts L; Nedeltchev K; Bertschi M; Gschwind M
J Neurol; 2023 Jun; 270(6):3258-3260. PubMed ID: 36856845
[No Abstract] [Full Text] [Related]
12. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
14. Anti-Homer-3 antibody associated cerebellar ataxia: A rare case report and literature review.
Xu X; Ren H; Li L; Wang J; Fechner K; Guan H
J Neuroimmunol; 2019 May; 330():155-158. PubMed ID: 30904736
[TBL] [Abstract][Full Text] [Related]
15. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
16. GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin-Associated Ataxia and Neuropathy.
Pittock SJ; Alfugham N; O'Connor K; Hinson S; Kunchok A; Lennon VA; Komorowski L; Probst C; McKeon A
Mov Disord Clin Pract; 2020 Nov; 7(8):904-909. PubMed ID: 33163561
[TBL] [Abstract][Full Text] [Related]
17. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
Planche V; Marques A; Ulla M; Ruivard M; Durif F
Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
[TBL] [Abstract][Full Text] [Related]
19. [An elderly man with progressive ataxia and palatal tremor presenting with dizziness and oculopalatal tremor].
Tsukahara Y; Suzuki K; Kokubun N; Nakamura T; Takekawa H; Hirata K
Rinsho Shinkeigaku; 2016 Aug; 56(8):560-4. PubMed ID: 27477579
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.
Aguiar TS; Fragoso A; Albuquerque CR; Teixeira PF; Souza MV; Zajdenverg L; Alves-Leon SV; Rodacki M; Lima MA
Arq Neuropsiquiatr; 2017 Mar; 75(3):142-146. PubMed ID: 28355320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
